AstraZeneca and 5 Others Caught for Violating China’s Human Genetic Regulation: Clinical Data Rejected
The Ministry of Science and Technology of China imposed penalties today (Oct 24th) on 6 companies for violating regulations on human genetic resources. AstraZeneca and 5 domestic companies are on